A study on pharmacodynamics and toxicology of high-dose methotrxate for treating children acute lymphoblastic leukemia

魏盈盈,焦溦溦,程思,丁水平,曹舒雯,郑恒,刘东,杜光,刘爱国

DOI: https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2014.22.09

2014-01-01

Abstract:OBJECTIVE To explore the connection among 48,72 h plasma concentration,excretion delay and adverse reactions in children acute lymphoblastic leukemia(ALL)with high-dose methotrexate therapy by monitoring plasma concentration.METHODS 37 cases of children patients with acute lymphoblastic leukemia were measured by EMIT which received 188 times HD-MTX treatment,leucovorin(CF)doses were adjusted by the 48 h,72 h plasma concentration,meanwhile adverse reactions were observed.RESULTS In B-ALL children,the plasma concentration 48 h≥1.16μmol·L-1 group compared with48 h1.16μmol·L-1 group,there were significant differences in gastrointestinal reactions,mucosal lesions,and a higher incidence of renal impairment;the blood concentration 72 h≥0.22μmol·L-1 group compared with 72 h0.22μmol·L-1 group,there were significant differences in gastrointestinal reactions,renal dysfunction,and a higher incidence of respiratory reactions.In T-ALL children,the plasma concentration48 h≥1.16μmol·L-1 group compared with48 h1.16μmol·L-1 group,there were significant differences in renal dysfunction,a higher incidence of respiratory reactions.CONCLUSION There are correlations between plasma concentrations and adverse reactions,MTX plasma concentration monitoring can better guide the clinical treatment of children suffering from ALL.